annual current assets:
$714.27M+$276.13M(+63.02%)Summary
- As of today (September 18, 2025), RXRX annual total current assets is $714.27 million, with the most recent change of +$276.13 million (+63.02%) on December 31, 2024.
- During the last 3 years, RXRX annual current assets has risen by +$179.55 million (+33.58%).
- RXRX annual current assets is now at all-time high.
Performance
RXRX Current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current assets:
$587.16M+$3.02M(+0.52%)Summary
- As of today (September 18, 2025), RXRX quarterly total current assets is $587.16 million, with the most recent change of +$3.02 million (+0.52%) on June 30, 2025.
- Over the past year, RXRX quarterly current assets has increased by +$64.78 million (+12.40%).
- RXRX quarterly current assets is now -17.80% below its all-time high of $714.27 million, reached on December 31, 2024.
Performance
RXRX quarterly current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
RXRX Current assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +63.0% | +12.4% |
3 y3 years | +33.6% | +7.5% |
5 y5 years | +834.9% | - |
RXRX Current assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +63.0% | -17.8% | +70.9% |
5 y | 5-year | at high | +834.9% | -17.8% | +164.7% |
alltime | all time | at high | +834.9% | -17.8% | +164.7% |
RXRX Current assets History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $587.16M(+0.5%) |
Mar 2025 | - | $584.14M(-18.2%) |
Dec 2024 | $734.33M(+240.7%) | $714.27M(+50.6%) |
Sep 2024 | - | $474.17M(-9.2%) |
Jun 2024 | - | $522.38M(+52.0%) |
Mar 2024 | - | $343.62M(-21.6%) |
Dec 2023 | $215.56M(+64.0%) | $438.14M(+8.8%) |
Sep 2023 | - | $402.62M(-5.0%) |
Jun 2023 | - | $423.92M(-12.6%) |
Mar 2023 | - | $484.93M(-14.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $131.47M(+73.8%) | $569.81M(+18.3%) |
Sep 2022 | - | $481.62M(-11.8%) |
Jun 2022 | - | $546.00M(-11.9%) |
Mar 2022 | - | $619.46M(+15.8%) |
Dec 2021 | $75.63M(+135.2%) | $534.72M(-11.0%) |
Sep 2021 | - | $600.87M(-7.2%) |
Jun 2021 | - | $647.63M(+192.0%) |
Mar 2021 | - | $221.82M(-16.7%) |
Dec 2020 | $32.15M(+28.4%) | - |
Dec 2020 | - | $266.44M |
Dec 2019 | $25.03M | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual total current assets?
- What is the all time high annual current assets for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual current assets year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly total current assets?
- What is the all time high quarterly current assets for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly current assets year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual total current assets?
The current annual current assets of RXRX is $714.27M
What is the all time high annual current assets for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual total current assets is $714.27M
What is Recursion Pharmaceuticals, Inc. annual current assets year-on-year change?
Over the past year, RXRX annual total current assets has changed by +$276.13M (+63.02%)
What is Recursion Pharmaceuticals, Inc. quarterly total current assets?
The current quarterly current assets of RXRX is $587.16M
What is the all time high quarterly current assets for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly total current assets is $714.27M
What is Recursion Pharmaceuticals, Inc. quarterly current assets year-on-year change?
Over the past year, RXRX quarterly total current assets has changed by +$64.78M (+12.40%)